Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2011; 17(21): 2658-2662
Published online Jun 7, 2011. doi: 10.3748/wjg.v17.i21.2658
Published online Jun 7, 2011. doi: 10.3748/wjg.v17.i21.2658
Table 1 Clinical parameters of esophageal squamous cell carcinoma patients and healthy controls n (%)
| ESCC patients (n = 72) | Healthy controls (n = 83) | |
| Age (yr) | ||
| < 50 | 5 (7) | 16 (19) |
| ≥ 50 | 67 (93) | 67 (81) |
| Gender | ||
| Male | 52 (72) | 45 (54) |
| Female | 20 (28) | 38 (46) |
| Histological grade | ||
| Well | 16 (22) | - |
| Well/moderate | 2 (3) | - |
| Moderate | 33 (46) | - |
| Moderate/poor | 3 (4) | - |
| Poor | 15 (21) | - |
| Unknown | 3 (4) | - |
| Tumor size (cm) | ||
| < 5 | 32 (44) | - |
| ≥ 5 | 37 (51) | - |
| Unknown | 3 (5) | - |
| TNM stage | ||
| I | 14 (19) | - |
| II | 21 (29) | - |
| III | 31 (43) | - |
| Unknown | 6 (8) | - |
| Lymph node metastasis | ||
| Yes | 34 (47) | - |
| No | 31 (43) | - |
| Unknown | 7 (10) | - |
- Citation: Dong QM, Zhang JQ, Li Q, Bracher JC, Hendricks DT, Zhao XH. Clinical significance of serum expression of GROβ in esophageal squamous cell carcinoma. World J Gastroenterol 2011; 17(21): 2658-2662
- URL: https://www.wjgnet.com/1007-9327/full/v17/i21/2658.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i21.2658